Using Remimazolam to Improve Recovery After Stomach Surgery for Cancer
Official title: Effect and Mechanism of Remimazolam Benzenesulfonate on Eenhanced Recovery After Surgery in Patients Undergoing Radical Gastrectomy for Gastric Cancer
Run by Shaoxing Hospital of Zhejiang University · NCT05559151 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing if a medication called Remimazolam can help people recover better after stomach surgery for cancer compared to another medication called Propofol.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Shaoxing Hospital of Zhejiang University Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Shaoxing, Zhejiang) |
| Trial ID | NCT05559151 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 18-75 undergoing elective laparoscopic radical gastrectomy for gastric cancer.
✕Probably not a fit
Patients who may not benefit include those under 18 or over 75, those with severe comorbidities, or those with a history of substance abuse.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of Remimazolam Benzenesulfonate on postoperative recovery in patients undergoing radical gastrectomy for gastric cancer. A total of 60 patients will be randomly assigned to receive either Remimazolam or Propofol during their surgery, with the aim of comparing recovery outcomes and inflammatory responses between the two groups. The study will monitor various parameters, including postoperative complications, recovery times, and inflammatory cytokine levels, to assess the potential benefits of Remimazolam in enhancing recovery after surgery.
Why it matters
Potential benefit: If successful, this approach could lead to improved recovery times and reduced complications for patients undergoing radical gastrectomy.
How similar studies have gone: Other studies have shown promising results with similar anesthetic approaches, suggesting potential for success in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Sixty patients undergoing elective laparoscopic radical gastrectomy for gastric cancer; aged 18-75 years; ASA≤ⅲ . - Exclusion Criteria: Emergency surgery or non-radical gastrectomy patients; age \< 18 or \> 75 years old, ASA grade ≥IV. Benzodiazepines or other narcotic drug allergy patients; patients with neurological and psychiatric disorders, long-term use of sedatives or antidepressants; has a history of alcoholism or drug dependence; intraoperative find distant metastasis; receive radiation and chemotherapy, cachexia; patients with a history of other malignant tumors within five years; the patient refused to participate in the study. -
Where it's running
-
Shaoxing People's Hospital
Shaoxing, Zhejiang, China Recruiting
Study contacts
- Study coordinator: zhonghua chen, master's degree
- Email: chenbeijing116@163.com
- Phone: 13625751526
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.